Supported by over two decades of international experience in regulatory approval, health-technology-assessment, clinical data generation & commercial sales, Stratarium Sàrl collaborates with innovative technology medtechs to establish awareness and credibility in selected markets, including the complex single-payer UK market

Stratarium seeks to work with recently commercialised or pre-commercial technologies that address a specific clinical need, to then establish real-world-evidence clinical evaluations that generate credibility and near-term commercial opportunities

Stratarium’s unique offering is to invest its own resources and share risk with manufacturers, in exchange for an appropriate return based on agreed objectives

Please do not hesitate to contact us to discuss your needs